Edgewood Oncology

Brookline, United States

Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.

$20.0M raised

Mar 2024

Series A

Biotechnology

Top Investors

Alta Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Edgewood Oncology

How much funding has Edgewood Oncology raised?

Edgewood Oncology has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.

Who are Edgewood Oncology's investors?

Edgewood Oncology's investors include Alta Partners.

Where is Edgewood Oncology headquartered?

Edgewood Oncology is headquartered in Brookline, United States.

What does Edgewood Oncology do?

Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.

What stage is Edgewood Oncology at?

Edgewood Oncology is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 25, 2024.

MLA

"Edgewood Oncology — Funding & Investors." VCBacked, March 25, 2024, https://www.vcbacked.co/company/edgewood-oncology. Accessed July 2, 2026.

APA

VCBacked. (2024). Edgewood Oncology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/edgewood-oncology

Wikipedia (cite web)

{{cite web |title=Edgewood Oncology — Funding & Investors |url=https://www.vcbacked.co/company/edgewood-oncology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 25, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K